Ardent Health Reports $6.32 Billion Revenue for Fiscal Year 2025, Net Income Declines

Ardent Health, Inc. reported a total revenue of $6.32 billion for the fiscal year ending December 31, 2025, marking a 6.0% increase from $5.97 billion in 2024. The growth was driven by a 2.3% rise in adjusted admissions and a 3.5% increase in net patient service revenue per adjusted admission. The company served approximately 1.2 million unique patients, with over 6.1 million visits across its network of 30 acute care hospitals and more than 280 care sites. However, net income attributable to Ardent Health, Inc. decreased to $135.8 million, down from $210.3 million in the previous year, primarily due to increased professional liability losses and a change in accounting estimates related to accounts receivable collectability.

In terms of operational metrics, Ardent's adjusted admissions rose to 349,614, while inpatient surgeries increased by 6.5% to 38,288. The company also experienced a slight decline in outpatient surgeries, which totaled 91,361. The increase in operating expenses was notable, with total operating expenses rising to $6.04 billion, or 95.5% of total revenue, compared to 93.9% in 2024. This increase was largely attributed to higher professional fees and general liability losses, particularly in the New Mexico market.

Strategically, Ardent Health has been active in expanding its footprint, acquiring 18 urgent care centers in New Mexico and Oklahoma for $27.5 million in January 2025. The company also completed its initial public offering (IPO) in July 2024, raising approximately $192 million, which has provided additional capital for growth initiatives. The IPO allowed Ardent to convert from a limited liability company to a corporation, enhancing its corporate structure for future operations.

Looking ahead, Ardent Health anticipates continued growth driven by its consumer-centric healthcare model and strategic joint ventures with academic medical centers and not-for-profit health systems. The company aims to enhance its market share in existing regions while exploring opportunities in new mid-sized urban markets. However, it faces challenges from regulatory changes, particularly in Medicaid and Medicare reimbursement structures, as well as ongoing labor shortages and rising operational costs. The company’s management remains focused on leveraging technology and improving care delivery to navigate these challenges effectively.